Samuel Martel
Impact in
-
- Cancer Risks and Factors
- PARP inhibition in cancer therapy
- HER2/EGFR in Cancer Research
-
- Advanced Breast Cancer Therapies
Papers in
- Oncology 14
- Cancer Risks and Factors 5
- HER2/EGFR in Cancer Research 4
- Cancer Treatment and Pharmacology 2
- Lung Cancer Research Studies 1
-
- Advanced Breast Cancer Therapies 9
- Co-authors
- Christian Maurer (14 shared papers)Matteo Lambertini (15 shared papers)Evandro de Azambuja (15 shared papers)Noam Pondé (10 shared papers)Martine Piccart (10 shared papers)Arlindo R. Ferreira (6 shared papers)Lucia Del Mastro (6 shared papers)Michail Ignatiadis (3 shared papers)
In The Last Decade
Samuel Martel
20 papers receiving 291 citations
Peers
Comparison fields: 5 of 46
- Oncology 183
- Pulmonary and Respiratory Medicine 99
- Cancer Research 42
- Cardiology and Cardiovascular Medicine 29
- Reproductive Medicine 9
Countries citing papers authored by Samuel Martel
This map shows the geographic impact of Samuel Martel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Samuel Martel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Samuel Martel more than expected).
Fields of papers citing papers by Samuel Martel
This network shows the impact of papers produced by Samuel Martel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Samuel Martel. The network helps show where Samuel Martel may publish in the future.
Co-authors
The 25 scholars most cited alongside Samuel Martel, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 22 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 52 | |
| 2 | 2018 | 47 | |
| 3 | 2018 | 47 | |
| 4 | 2017 | 28 | |
| 5 | 2020 | 25 | |
| 6 | 2021 | 19 | |
| 7 | 2017 | 18 | |
| 8 | 2017 | 16 | |
| 9 | 2018 | 11 | |
| 10 | 2014 | 10 | |
| 11 | 2022 | 9 | |
| 12 | 2025 | 3 | |
| 13 | 2025 | 2 | |
| 14 | 2018 | 2 | |
| 15 | 2019 | 1 | |
| 16 | 2023 | 1 | |
| 17 | 2021 | 1 | |
| 18 | 2017 | 1 | |
| 19 | 2020 | 1 | |
| 20 | 2024 | 1 |
About Samuel Martel
Samuel Martel is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Cancer Research, Molecular Biology and Dermatology, having authored 22 papers that have together received 295 indexed citations. Recurring topics across this work include Advanced Breast Cancer Therapies (9 papers), Cancer Risks and Factors (5 papers), HER2/EGFR in Cancer Research (4 papers), Breast Cancer Treatment Studies (3 papers), Cancer Treatment and Pharmacology (2 papers), Lung Cancer Research Studies (1 paper), Cancer Genomics and Diagnostics (1 paper) and Autoimmune Neurological Disorders and Treatments (1 paper). The work is most often cited by research in Oncology (183 citations), Pulmonary and Respiratory Medicine (99 citations), Cancer Research (42 citations), Cardiology and Cardiovascular Medicine (29 citations) and Reproductive Medicine (9 citations). Samuel Martel has collaborated with scholars based in Belgium, Canada and Germany. Frequent co-authors include Christian Maurer, Matteo Lambertini, Evandro de Azambuja, Noam Pondé, Martine Piccart, Arlindo R. Ferreira, Lucia Del Mastro, Michail Ignatiadis, Marco Bruzzone and Marcello Ceppi. Their work appears in journals such as Journal of Clinical Oncology, ESMO Open, The Breast, European Journal of Cancer and Expert Opinion on Drug Safety.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.